Nascent Biotech Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2016 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Nascent Biotech Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q3 2016 to Q4 2022.
  • Nascent Biotech Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $0.000.
  • Nascent Biotech Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Nascent Biotech Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Nascent Biotech Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $0 $0 Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-14
Q4 2021 $0 Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2016 $240K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.